Literature DB >> 21693080

Anterograde-retrograde rendezvous approach for radiation-induced complete upper oesophageal sphincter stenosis: case report and literature review.

M P Kos1, E F David, H F Mahieu.   

Abstract

BACKGROUND: Strictures of the hypopharynx and oesophagus are frequently observed following (chemo)radiation. Anterograde dilatation of a complete stenosis carries a high risk of perforation. An alternative is described: a combined anterograde-retrograde approach. CASE REPORT: A 75-year-old man developed complete stenosis of the oesophageal inlet after primary radiotherapy for laryngeal carcinoma and full percutaneous endoscopic gastrostomy feeding. To prevent creation of a false route into the mediastinum, a dilatation wire was introduced in a retrograde fashion into the oesophagus, through the gastrostomy opening. The wire was endoscopically identified from the proximal side and then passed through a perforation created by CO2 laser. Anterograde dilatation was safely performed, and the patient returned to a normal diet. There is consensus in the literature that blind anterograde dilatation carries a high risk of perforation; therefore, an anterograde-retrograde rendezvous technique is advisable.
CONCLUSION: In cases of complete obstruction of the oesophageal inlet, anterograde-retrograde dilatation represents a safe technique with which to restore enteric continuity.

Entities:  

Mesh:

Year:  2011        PMID: 21693080     DOI: 10.1017/S0022215111001058

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  2 in total

1.  Endoscopic Approach to Reopening a Completely Obstructed Esophagus.

Authors:  Richard A Kozarek
Journal:  Gastroenterol Hepatol (N Y)       Date:  2015-08

2.  Outcomes of serial dilation for high-grade radiation-related esophageal strictures in head and neck cancer patients.

Authors:  David O Francis; Eric Hall; Jennifer H Dang; Gregory R Vlacich; James L Netterville; Michael F Vaezi
Journal:  Laryngoscope       Date:  2014-10-24       Impact factor: 3.325

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.